Seroatlas · Human Serome Atlas

IRF2BPL

Probable E3 ubiquitin-protein ligase IRF2BPL

Also known as: C14orf4, EAP1, I2BPL_HUMAN, KIAA1865

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9H1B7
Gene
IRF2BPL
Ensembl
ENSG00000119669
Chromosome
14
Canonical length
796 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Nucleoplasm

OverviewNCBI Gene

This gene encodes a transcription factor that may play a role in regulating female reproductive function. [provided by RefSeq, Jun 2012]

Canonical amino-acid sequenceUniProt

796 residues, UniProt reviewed canonical sequence.

>Q9H1B7|IRF2BPL
     1  MSAAQVSSSR RQSCYLCDLP RMPWAMIWDF SEPVCRGCVN YEGADRIEFV IETARQLKRA
    61  HGCFQDGRSP GPPPPVGVKT VALSAKEAAA AAAAAAAAAA AAQQQQQQQQ QQQQQQQQQQ
   121  QQQQQQQLNH VDGSSKPAVL AAPSGLERYG LSAAAAAAAA AAAAVEQRSR FEYPPPPVSL
   181  GSSSHTARLP NGLGGPNGFP KPTPEEGPPE LNRQSPNSSS AAASVASRRG THGGLVTGLP
   241  NPGGGGGPQL TVPPNLLPQT LLNGPASAAV LPPPPPHALG SRGPPTPAPP GAPGGPACLG
   301  GTPGVSATSS SASSSTSSSV AEVGVGAGGK RPGSVSSTDQ ERELKEKQRN AEALAELSES
   361  LRNRAEEWAS KPKMVRDTLL TLAGCTPYEV RFKKDHSLLG RVFAFDAVSK PGMDYELKLF
   421  IEYPTGSGNV YSSASGVAKQ MYQDCMKDFG RGLSSGFKYL EYEKKHGSGD WRLLGDLLPE
   481  AVRFFKEGVP GADMLPQPYL DASCPMLPTA LVSLSRAPSA PPGTGALPPA APSGRGAAAS
   541  LRKRKASPEP PDSAEGALKL GEEQQRQQWM ANQSEALKLT MSAGGFAAPG HAAGGPPPPP
   601  PPLGPHSNRT TPPESAPQNG PSPMAALMSV ADTLGTAHSP KDGSSVHSTT ASARRNSSSP
   661  VSPASVPGQR RLASRNGDLN LQVAPPPPSA HPGMDQVHPQ NIPDSPMANS GPLCCTICHE
   721  RLEDTHFVQC PSVPSHKFCF PCSRESIKAQ GATGEVYCPS GEKCPLVGSN VPWAFMQGEI
   781  ATILAGDVKV KKERDP

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IRF2BPL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.56
Highest tissue expression
31 nTPM

Expression across tissuesHPA

Tissue

  • blood vessel: 31 nTPM
  • ovary: 30 nTPM
  • colon: 30 nTPM
  • breast: 27 nTPM
  • fallopian tube: 25 nTPM
  • adipose tissue: 25 nTPM

Single-cell type

  • neutrophils: 172 nCPM
  • undifferentiated spermatogonia: 107 nCPM
  • smooth muscle cells: 80 nCPM
  • extravillous trophoblasts: 75 nCPM
  • basal keratinocytes: 73 nCPM
  • vascular smooth muscle cells: 72 nCPM

Immune cell

  • plasmacytoid DC: 11 nTPM
  • neutrophil: 9 nTPM
  • NK-cell: 5.9 nTPM
  • gdT-cell: 2.8 nTPM
  • MAIT T-cell: 2.7 nTPM
  • memory CD8 T-cell: 2.6 nTPM

Brain region

  • hypothalamus: 65 nTPM
  • medulla oblongata: 53 nTPM
  • midbrain: 53 nTPM
  • hippocampal formation: 50 nTPM
  • basal ganglia: 49 nTPM
  • cerebellum: 48 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about IRF2BPL.

Disease | AllUniProt

Conditions IRF2BPL is implicated in, by any mechanism.

Disease | GeneticClinVar

98 pathogenic / likely-pathogenic of 574 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.41
gnomAD pLI
0.84
gnomAD missense Z
0.73
DepMap mean gene effect
-0.05
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of IRF2BPL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IRF2BPL as an antibody target. Whether an autoantibody or antibody against IRF2BPL could matter depends on whether native IRF2BPL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IRF2BPL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label IRF2BPL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IRF2BPL. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...